We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Navitas Semiconductor
NVTS
$3.57B
| $8.74M | 0.04% |
829,128
+804,816
| +3,310% | +$6.23M |
|
|
ACLX
502
DELISTED
Arcellx
ACLX
| $8.68M | 0.04% |
274,571
+119,418
| +77% | +$4.57M |
|
503
Sanmina
SANM
$11.1B
| $8.66M | 0.04% |
143,663
+5,724
| +4% | +$314K |
|
504
National Vision
EYE
$1.51B
| $8.66M | 0.04% |
356,341
-195,689
| -35% | -$4.55M |
|
505
CVB Financial
CVBF
$4.08B
| $8.58M | 0.04% |
645,913
+330,428
| +105% | +$4.56M |
|
506
Bio-Rad Laboratories Class A
BIO
$9.66B
| $8.55M | 0.04% |
+22,557
| New | +$9.18M |
|
507
Cameco
CCJ
$42.6B
| $8.54M | 0.04% |
+272,640
| New | +$7.67M |
|
508
ManpowerGroup
MAN
$2.75B
| $8.5M | 0.04% |
107,107
+33,584
| +46% | +$2.53M |
|
509
Kinross Gold
KGC
$31.9B
| $8.44M | 0.04% |
+1,770,224
| New | +$8.84M |
|
510
Life Time Group Holdings
LTH
$9.9B
| $8.44M | 0.04% |
429,148
+143,671
| +50% | +$2.75M |
|
|
PENG
511
Penguin Solutions Inc
PENG
$3.12B
| $8.43M | 0.04% |
290,671
+115,848
| +66% | +$2.32M |
|
|
PDCO
512
DELISTED
Patterson Companies, Inc.
PDCO
| $8.36M | 0.04% |
251,243
+223,931
| +820% | +$6.17M |
|
|
SQSP
513
DELISTED
Squarespace, Inc.
SQSP
| $8.35M | 0.04% |
264,781
+119,761
| +83% | +$3.62M |
|
514
Perion Network
PERI
$384M
| $8.34M | 0.04% |
271,838
+88,927
| +49% | +$3.05M |
|
515
Stellantis
STLA
$20.2B
| $8.33M | 0.04% |
474,870
+195,677
| +70% | +$3.28M |
|
516
United Microelectronic
UMC
$48.6B
| $8.29M | 0.04% |
1,051,266
+793,376
| +308% | +$6.54M |
|
517
Alliant Energy
LNT
$18.2B
| $8.26M | 0.04% |
157,396
-53,169
| -25% | -$2.85M |
|
518
BridgeBio Pharma
BBIO
$15.9B
| $8.25M | 0.04% |
479,451
-563,035
| -54% | -$8.47M |
|
519
Avantor
AVTR
$9.37B
| $8.24M | 0.04% |
+401,160
| New | +$8.11M |
|
520
Petrobras Class A
PBR.A
$104B
| $8.21M | 0.04% |
663,548
+557,921
| +528% | +$6.08M |
|
|
HZNP
521
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.2M | 0.04% |
79,737
-31,983
| -29% | -$3.37M |
|
522
Stryker
SYK
$131B
| $8.13M | 0.04% |
+26,659
| New | +$7.7M |
|
523
Lightspeed Commerce
LSPD
$1.42B
| $8.09M | 0.04% |
478,142
+56,058
| +13% | +$806K |
|
524
Maravai LifeSciences
MRVI
$861M
| $8.08M | 0.04% |
650,296
+14,529
| +2% | +$196K |
|
525
Ericsson
ERIC
$33.6B
| $7.94M | 0.04% |
1,457,666
-2,992,265
| -67% | -$16.1M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.